Knipper Health, a leading healthcare solutions organization serving the pharmaceutical, biotechnology, and medical device ...

AmerisourceBergen’s move into the digital health area is part of a revamp of the business, which will be renamed Cencora later this year to reflect a change in business strategy, with ...

Outlook has teamed up with Cencora (formerly AmerisourceBergen) and its European partners to support commercialisation of Lytenava in the UK and selected EU countries, and has said it plans to ...

Cencora (COR), which belongs to the Zacks Medical Services industry, could be a great candidate to consider. This prescription drug distributor has seen a nice streak of beating earnings estimates ...

$60,000 of CENCORA INC. lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "IRA implementation. Drug Shortages ...

Cencora COR has outperformed the market over the past 10 years by 9.42% on an annualized basis producing an average annual return of 19.01%. Currently, Cencora has a market capitalization of $55. ...

Citi analyst Daniel Grosslight maintained a Buy rating on Cencora (COR – Research Report) today and set a price target of $330.00. The company’s shares closed yesterday at $284.44. Discover ...

In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against other stocks that Jim Cramer discusses. On Friday, Mad Money host, Jim Cramer, shared his perspective ...